A Phase I, Single Centre, Randomized, Open-Label, Three-Period Crossover Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA With a Single 4 g Dose of AZD0585 in Healthy Male Japanese Subjects

Trial Profile

A Phase I, Single Centre, Randomized, Open-Label, Three-Period Crossover Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA With a Single 4 g Dose of AZD0585 in Healthy Male Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 17 May 2016

At a glance

  • Drugs Omega-3 carboxylic acids (Primary)
  • Indications Unspecified
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 26 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 07 Apr 2015 Planned End Date changed from 1 May 2015 to 1 Apr 2015, as reported by ClinicalTrials.gov.
    • 07 Apr 2015 Planned primary completion date changed from 1 May 2015 to 1 Apr 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top